| Use Additional |
| code to identify resistance to antimicrobial drugs (Z16-) |
| Includes |
| diseases generally recognized as communicable or transmissible |
| Type 1 Excludes |
| certain localized infections - see body system-related chapters |
| Type 2 Excludes |
| infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium (O98.-) |
| influenza and other acute respiratory infections (J00-J22) |
| carrier or suspected carrier of infectious disease (Z22.-) |
| infectious and parasitic diseases specific to the perinatal period (P35-P39) |
|
A00-A09 |
| Intestinal infectious diseases (A00-A09) |
|
A15-A19 |
| Tuberculosis (A15-A19) |
|
A20-A28 |
| Certain zoonotic bacterial diseases (A20-A28) |
|
A30-A49 |
| Other bacterial diseases (A30-A49) |
|
A50-A64 |
| Infections with a predominantly sexual mode of transmission (A50-A64) |
|
A65-A69 |
| Other spirochetal diseases (A65-A69) |
|
A70-A74 |
| Other diseases caused by chlamydiae (A70-A74) |
|
A75-A79 |
| Rickettsioses (A75-A79) |
|
A80-A89 |
| Viral and prion infections of the central nervous system (A80-A89) |
|
A90-A99 |
| Arthropod-borne viral fevers and viral hemorrhagic fevers (A90-A99) |
|
B00-B09 |
| Viral infections characterized by skin and mucous membrane lesions (B00-B09) |
|
B10-B10 |
| Other human herpesviruses (B10) |
|
B15-B19 |
| Viral hepatitis (B15-B19) |
|
B20-B20 |
| Human immunodeficiency virus [HIV] disease (B20) |
|
B25-B34 |
| Other viral diseases (B25-B34) |
|
B35-B49 |
| Mycoses (B35-B49) |
|
B50-B64 |
| Protozoal diseases (B50-B64) |
|
B65-B83 |
| Helminthiases (B65-B83) |
|
B85-B89 |
| Pediculosis, acariasis and other infestations (B85-B89) |
|
B90-B94 |
| Sequelae of infectious and parasitic diseases (B90-B94) |
|
B95-B97 |
| Bacterial and viral infectious agents (B95-B97) |
|
B99-B99 |
| Other infectious diseases (B99) |